Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murad Atmaca

Showing results (71-80 of 173) with videos related to

Pageof 18
Sort By:
Frontiers in Psychiatry|December 29, 2025
Claudin-5 and inflammatory biomarkers in panic disorder: a 6-week follow-up studyDilek Örüm, Zekiye Çatak, Ali Baran Tanrıkulu, et al.
Neuropsychobiology|July 5, 2002
Serum cholesterol and leptin levels in patients with borderline personality disorderMurad Atmaca, Muloglu Kuloglu, Ertan Tezcan, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 21, 2002
Neopterin levels and dexamethasone suppression test in posttraumatic stress disorderMurad Atmaca, Murat Kuloglu, Ertan Tezcan, et al.
Schizophrenia Research|December 31, 2002
Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidolMurad Atmaca, Murat Kuloglu, Ertan Tezcan, et al.
Human Psychopharmacology|January 13, 2004
Nizatidine for the treatment of patients with quetiapine-induced weight gainMurad Atmaca, Murat Kuloglu, Ertan Tezcan, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 17, 2004
Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatmentMurad Atmaca, E Tezcan, M Kuloglu, et al.
Psychological Medicine|November 11, 2006
Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapineMurad Atmaca, Hanefi Yildirim, Huseyin Ozdemir, et al.
Asian Journal of Psychiatry|August 9, 2017
Orbito-frontal cortex volumes in patients with antisocial personality disorderMurad Atmaca, Suheda Kaya, Ismail Taskent, et al.
Neuropsychobiology|February 5, 2003
Antioxidant enzyme and malondialdehyde levels in patients with panic disorderMurat Kuloglu, Murad Atmaca, Ertan Tezcan, et al.
Psychiatry Research|March 7, 2017
Determination of health anxiety, anxiety, and somatosensory amplification levels in individuals with normal coronary angiographyHasan Korkmaz, Sevda Korkmaz, Sevler Yildiz, et al.
Pageof 18

Showing results (71-80 of 173) with videos related to

Sort By:
Pageof 18
Frontiers in Psychiatry|December 29, 2025
Claudin-5 and inflammatory biomarkers in panic disorder: a 6-week follow-up studyDilek Örüm, Zekiye Çatak, Ali Baran Tanrıkulu, et al.
Neuropsychobiology|July 5, 2002
Serum cholesterol and leptin levels in patients with borderline personality disorderMurad Atmaca, Muloglu Kuloglu, Ertan Tezcan, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 21, 2002
Neopterin levels and dexamethasone suppression test in posttraumatic stress disorderMurad Atmaca, Murat Kuloglu, Ertan Tezcan, et al.
Schizophrenia Research|December 31, 2002
Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidolMurad Atmaca, Murat Kuloglu, Ertan Tezcan, et al.
Human Psychopharmacology|January 13, 2004
Nizatidine for the treatment of patients with quetiapine-induced weight gainMurad Atmaca, Murat Kuloglu, Ertan Tezcan, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 17, 2004
Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatmentMurad Atmaca, E Tezcan, M Kuloglu, et al.
Psychological Medicine|November 11, 2006
Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapineMurad Atmaca, Hanefi Yildirim, Huseyin Ozdemir, et al.
Asian Journal of Psychiatry|August 9, 2017
Orbito-frontal cortex volumes in patients with antisocial personality disorderMurad Atmaca, Suheda Kaya, Ismail Taskent, et al.
Neuropsychobiology|February 5, 2003
Antioxidant enzyme and malondialdehyde levels in patients with panic disorderMurat Kuloglu, Murad Atmaca, Ertan Tezcan, et al.
Psychiatry Research|March 7, 2017
Determination of health anxiety, anxiety, and somatosensory amplification levels in individuals with normal coronary angiographyHasan Korkmaz, Sevda Korkmaz, Sevler Yildiz, et al.
Pageof 18